Loading
Latest filing published 03 Aug 2021 for DA32 Life Science Tech Acquisition Corp., €6.7M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Section 32 Fund 3, LP in DA32 Life Science Tech Acquisition Corp. In total, 2 filings cover trades dated 30 July 2021.
No open-market sale appears; the market trades are 1 purchase worth €6.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
On 3 August 2021 came the latest disclosure, a share grant for €5.5M in DA32 Life Science Tech Acquisition Corp. The last purchase on record was published on 3 August 2021, which is 1,908 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration